Article
An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria
20 May 2020
Abstract excerpt
Clinical evaluation of genetically modified rodent malaria parasites for whole-sporozoite immunization against P. falciparum in healthy volunteers.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
